Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells-Reference-Cited by-同舟云学术

Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells

Published:2023-05 Issue: Volume:211 Page:115538
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

He Meng,Liao Qiuyu,Liu Dong,Dai Xufang,Shan Meihua,Yang Mingzhen,Zhang Yang,Zhai Liuyue,Chen Lingxi,Xiang Li,He Mei,Li Shuhui,Chen An,Sun Liangbo^ORCID,Lian Jiqin

Funder

National Natural Science Foundation of China

Natural Science Foundation of Chongqing

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference26 articles.

1. Current epidemiology in hepatocellular carcinoma;Konyn;Expert. Rev. Gastroent.,2021

2. Challenges in liver cancer and possible treatment approaches;Anwanwan;BBA-Rev Cancer,2020

3. Targeted therapy for hepatocellular carcinoma;Huang;Signal Transduct Tar,2020

4. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5;Liu;Cancer Res.,2006

5. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis;Leconte;Reprod. Sci.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine increases the killing effect of pirarubicin on HCC cells by inhibiting ATG4B-autophagy pathway;Experimental Cell Research;2024-06

2. Support Vector Machine-Based Prediction Models for Drug Repurposing and Designing Novel Drugs for Colorectal Cancer;ACS Omega;2024-04-09

3. Support Vector Machine based prediction models for drug repurposing and designing novel drugs for colorectal cancer;2023-10-23